Treatment of Obstructive Sleep Apnea with Maxillo-mandibular Advancement Surgery: Evaluation and Predictors of Success
Daniel Taub, DMD, MD; Michael Courtney, DMD, MD; and Karl Doghramji, MD
Obstructive sleep apnea (OSA) is a well-recognized disease entity affecting approximately 2% to 4% of the population. Maxillomandibular advancement (MMA) surgery is a highly successful surgical alternative to poorly tolerated CPAP therapy and achieves a success rate of 89% in the current literature. Our present study evaluates the effectiveness of MMA surgery in the treatment of patients with moderate to severe OSA based on Shers criteria of 50% reduction in AHI and AHI < 20. Radiographic and clinical treatment variables were evaluated in determining predictors of success for MMA in individuals with OSA.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.